Assignee
GENEURO SA
CH·8 granted patents·3 pending applications·9 citations·filing 2008–2021
Top patents by PatentIndex Score
11 records- 0191US10981977B2Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosisGENEURO SA·Filed 2020·Granted Apr 20, 2021·3 cites·6 claims
- 0278US10723787B2Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibodyGENEURO SA·Filed 2018·Granted Jul 28, 2020·2 cites·4 claims
- 0378US9815888B2Therapeutic use of specific ligand in MSRV associated diseasesGENEURO SA·Filed 2016·Granted Nov 14, 2017·2 cites·14 claims
- 0474US9550824B2Therapeutic use of specific ligand in MSRV associated diseasesGENEURO SA·Filed 2014·Granted Jan 24, 2017·2 cites·21 claims
- 0560US10059758B2Therapeutic use of specific ligand in MSRV associated diseasesGENEURO SA·Filed 2017·Granted Aug 28, 2018·0 cites·6 claims
- 0655US10894820B2Antiretroviral drug targeting human endogenous retrovirusGENEURO SA·Filed 2019·Granted Jan 19, 2021·0 cites·18 claims
- 0753US2024301040A1Anti-herv-w envelope protein antibody for use in the treatment of psychotic diseasesGENEURO SA·Filed 2021·Application pending·0 cites
- 0851US10752675B2Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope proteinGENEURO SA·Filed 2017·Granted Aug 25, 2020·0 cites·10 claims
- 0949US2010074894A1Pharmaceutical composition containing antibodies directed against the herv-w envelopeGENEURO SA·Filed 2008·Application pending·0 cites
- 1048US9840550B2Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope proteinGENEURO SA·Filed 2013·Granted Dec 12, 2017·0 cites·6 claims
- 1132US2017101461A1Antiretroviral Drug Targeting Human Endogenous RetrovirusGENEURO SA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENEURO SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →